Are we in for a cat boom? We’re paws-itively sure of it (sorry!). Swiss company HypoPet AG has created the HypoCat vaccine, which coaxes a cat’s immune system into producing less of a protein that causes allergic reactions in 10% of humans. Search interest in HypoCat spiked after updates on the vaccine last month.
Early adopters: The vaccine is not expected to be available until 2022. US cat ownership has already increased by 20%, to 47m, since 2011. HypoCat will likely increase ownership further, creating more opportunities for pet-specific and cat-specific industries.